Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Ellis, IO, Nicholson, RI and Robertson, JF 2001. Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. International Journal of Cancer 95 (4) , pp. 247-54. 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy
ISSN:	10970215
Last Modified:	17 Oct 2022 08:45
URI:	https://orca.cardiff.ac.uk/id/eprint/982

Citation Data

Cited 212 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item